The effect of novel simple saffron syrup on fatigue reduction in patients with multiple sclerosis

Autor: Mehdi Salehi, Latifi Seied Amirhossein, Alireza rezaee ashtiani, Seyed Mohamad Aghae Pour, Abbas Alimoradian, Keyvan Ghasami, Ali Jadidi, Ali Khanmohamadi Hezave, Mohammad Kamalinejad, Shema Malekhosseni

Publikováno v: Journal of Basic and Clinical Physiology and Pharmacology. 31

Objectives Multiple sclerosis (MS) is a progressive and often debilitating neurological disorder. This chronic disease has a high prevalence in the world and also in Iran. Fatigue is a common symptom of the disease, which causes serious mental and ps

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a75314d1bcf918938dce5d5892c11282
https://doi.org/10.1515/jbcpp-2020-0063

Characterization of Regulatory T-Cells in Multiple Sclerosis Patients Treated with Interferon Beta-1a

Autor: Ali Ganji, Keyvan Ghasami, Ghasem Mosayebi, Sara Zahedi, Mohsen Ebrahimimonfared, Parisa Nourbakhsh

Publikováno v: CNSneurological disorders drug targets. 17(2)

Background: Regulatory T-Cells (Treg Cells), as one of the immune system components, have been highly effective in the autoimmune diseases prevention, particularly multiple sclerosis (MS). Cytokine-based therapies such as interferon beta-1a (IFN-β1a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b502c6bfd6b95ed7c8b0f1c4b30ee9dc
https://pubmed.ncbi.nlm.nih.gov/29589548

Multiple sclerosis (PP-038)

Autor: G. Fragoso, Christina Elliott, A. H. Nuyts, Y. Miyazaki, Y. Xu, T. Okazawa, H. Ochi, Y. Matsui, E. Montero, A. Mirshafiey, M. Izad, G. Lee, K. Fukuda, B. Balint, H. Kurata, A. Daniel Beyeen, E. S. Patrício, A. C. La Flamme, K. Shimano, T. Corona, H. Dougier-Reynaud, S. Miyake, H. Perron, T. Derfuss, E. Jouvin-Marche, T. Uede, D. O'Sulllivan, M. Hong, Reinhard Hohlfeld, S. Mader, M. Korporal, Z. Tan, R. Melarkode, S. Zhang, R. C. Dutra, Y. Lapierre, Z. Hruskova, T. Sugita, J. B. Pesquero, Z. N. Berneman, E. Kamali-Sarvestani, M. Khademi, P. Sämann, M. Trneny, M. Kadowaki, D. L. De la Cruz-Aguilera, B. Wildemann, H. Shinya, G. Nagels, Keyvan Ghasami, I. Kovarova, S. Vishwakarma, H. Mareckova, A. F. Bento, F. Gong, J. Gibbons, L. Duan, E. Zastepa, L. Aguirre-Cruz, D. Ganea, A. Tomita, A. Bar-Or, J. Antel, V. F. I. Van Tendeloo, J. Yen, D. Haegert, J. Hong, N. Yasuharu, L. Lee, C. Yao, J. Morimoto, Y. Yang, T. Okamoto, D. Sakata, J. Flores-Rivera, Ariel Arthur, Payani, Y. Esaki, J. K. M. Ng, M. Jagodic, Edgar Meinl, M. Krantz, Hema Mohan, Hartmut Wekerle, S. Jeon, J. Kira, I. Takaaki, M. Yanagida, M. Kharkrang, C. P. Figueiredo, W. Ma, T. S. Balmukhanov, M. Harirchian, N. Chihara, T. Yamamura, S. Satoru, Y. Miyamoto, K. Lenders, D. Hong, E. Krasulova, F. Zheng, W. Sato, M. Fang, L. Skacikova, N. Isobe, Z. Gheflati, B. Connor, D. Kurotaki, M. Ogawa, T. Olsson, E. Havrdova, H. Amiri Fard, Susan C. Barnett, S. Narumiya, J. Malotka, L. Chapul, L. Fitz-Gerald, J. Lee, B. Fritz, K. Motomura, T. Matsuoka, G. Tu, D. F. P. Leite, M. Koyama, H. Choi, K. Zenichiro, Ghasem Mosayebi, A. Fukunari, P. N. Marche, N. Seki, K. Ito, M. Vessal, E. Segi-Nishida, C. Bernard, Y. Kim, U. Makoto, P. Li, Y. Li, B. Agrawal, B. Willekens, A. Nikseresht, S. Zoghi, M. Minohara, Klaus Dornmair, X. Zeng, J. B. Calixto, A. Ortlieb Guerreiro-Cacais, S. Kim, F. Najafi, T. Matsushita, N. Cools, C. Lomparski, Yahya Jand, M. Kanayama, L. Steinman, S. Yoshimura, P. Nair, C. L. Villiers, K. Sugahara, Christopher Linington, R. H. Seong, K. Logronio, F. Satoshi, Hans Lassmann, T. Ikeda, H. Uga, M. Shin, M. Reindl, M. Ikeda, M. Rasband, D. Arnold, E. W. Loo, S. Tanaka, A. Duperray, S. He, D. Zhang, A. A. Smagin, N. A. Aitkhozhina, H. Kataoka, M. B. D'hooghe, J. Haas, R. Axtell, Z. Amirghofran, I. A. Goldina, Y. Funahashi, K. Chiba, M. r. Khazaei, T. Aranami, Ali Ghazavi, M. N. Manjavachi, F. Weber, S. M. Jeong, S. Patel, J. Lin, B. Stein, H. Bae, Y. Maeda, M. A. Mendesh, A. Schwarz, A. Jamshidian, Markus Krumbholz, K. Van Camp, T. Berger

Publikováno v: International Immunology. 22:i148-i155

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::15b46a77fd3f1f769d2a636c375c01b3
https://doi.org/10.1093/intimm/dxq125

Prognostic factors in acute stroke, regarding to stroke severity by Canadian Neurological Stroke Scale: A hospital-based study

Autor: Keyvan Ghasami, Fardin Faraji, Afsoon Talaie-Zanjani, Abolfazl Mohammadbeigi

Publikováno v: Asian Journal of Neurosurgery

Introduction: Stroke is an acute vascular disease and the second leading cause of death in the world. We have assessed the patients on hospital admission with some other prognostic factors besides the preliminary neurological examinations in order to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565f4a9152f3090b984e98158fb9c20c
https://pubmed.ncbi.nlm.nih.gov/24049549

Evaluation of viral antibodies in Iranian multiple sclerosis patients

Autor: Mohsen, Khaki, Ali, Ghazavi, Keyvan, Ghasami, Mohammad, Rafiei, Mohammah-Ali, Payani, Ehsanollah, Ghaznavi-Rad, Ghasem, Mosayebi

Publikováno v: Neurosciences (Riyadh, Saudi Arabia). 16(3)

To evaluate the viral antibodies in new Iranian multiple sclerosis (MS) patients.In a cross-sectional study, sera from 61 MS patients and 60 healthy individuals were collected from January 2009 to March 2010 in the Immunology Department of Arak Unive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4d958d78056287d44f217b900a286b5b
https://pubmed.ncbi.nlm.nih.gov/21677611